Drug intelligence / Profile preview

Repair Control EGF

Development stage
Unknown
Lead developer
Daewoong Pharmaceutical
Modality
Recombinant Proteins and Enzymes
Administration
Topical
01

Overview

**Repair Control EGF** is a topical EASYDEW EX skin-care product developed by DN Company and manufactured by Cosmax. Its labeled active ingredient is nepidermin, a recombinant human epidermal growth factor, at 0.001% concentration. Nepidermin is intended to activate epidermal growth factor receptor signaling in the skin, supporting epidermal-cell proliferation and repair. The product is supplied as a targeted external-use liquid treatment with an anti-wrinkle purpose; its formula also includes skin-conditioning and moisturizing excipients such as caffeine, ceramide NP, sodium hyaluronate, argan oil, and macadamia seed oil. The United States product label is categorized as an unapproved human OTC drug label rather than an FDA-approved therapeutic product. ([fda.report](https://fda.report/DailyMed/ac1dc30b-75a8-4955-8aea-8727ee6d7a3c))

Brand names
EASYDEW EX Repair Control Repair Control EGF
Other names
Easydew Repair Control EGF
02

Targets

Beyond the preview

Go deeper on Repair Control EGF.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Repair Control EGF.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call